Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
Elutia (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix products, has announced its participation in the LD Micro Main Event XVII Conference in Los Angeles. Dr. Randy Mills, President and CEO, will deliver a presentation on Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET). The company's management team will also be available for one-on-one meetings with institutional investors, who can schedule appointments through LD Micro representatives or by contacting IR@elutia.com.
Elutia (Nasdaq: ELUT), pioniere nei prodotti biomatrix a rilascio controllato di farmaci, ha annunciato la sua partecipazione alla LD Micro Main Event XVII Conference a Los Angeles. Dr. Randy Mills, Presidente e CEO, presenterà mercoledì 30 ottobre 2024, alle 14:00 PT (17:00 ET). Anche il team di gestione dell'azienda sarà disponibile per incontri individuali con gli investitori istituzionali, che possono prenotare appuntamenti tramite i rappresentanti di LD Micro o contattando IR@elutia.com.
Elutia (Nasdaq: ELUT), pionero en productos biomatrix que liberan fármacos, ha anunciado su participación en la LD Micro Main Event XVII Conference en Los Ángeles. Dr. Randy Mills, Presidente y CEO, ofrecerá una presentación el miércoles 30 de octubre de 2024, a las 2:00 p.m. PT (5:00 p.m. ET). El equipo de gestión de la empresa también estará disponible para reuniones uno a uno con inversores institucionales, que pueden programar citas a través de representantes de LD Micro o contactando a IR@elutia.com.
엘루티아 (Nasdaq: ELUT), 약물 방출 생체 매트릭스 제품의 선두주자가 로스앤젤레스에서 열리는 LD Micro Main Event XVII Conference에 참가한다고 발표했습니다. 랜디 밀스 박사, 사장 겸 CEO가 2024년 10월 30일 수요일 오후 2시 PT (오후 5시 ET)에 발표를 진행할 예정입니다. 또한 회사의 경영진 팀이 기관 투자자와의 일대일 회의에 참석할 수 있으며, 투자자들은 LD Micro 대표를 통해 약속을 예약하거나 IR@elutia.com으로 연락하여 약속을 잡을 수 있습니다.
Elutia (Nasdaq: ELUT), pionnier dans les produits biomatrix à libération de médicaments, a annoncé sa participation à la LD Micro Main Event XVII Conference à Los Angeles. Dr. Randy Mills, Président et CEO, donnera une présentation le mercredi 30 octobre 2024, à 14h00 PT (17h00 ET). L'équipe de direction de l'entreprise sera également disponible pour des réunions individuelles avec des investisseurs institutionnels, qui peuvent prendre des rendez-vous via des représentants de LD Micro ou en contactant IR@elutia.com.
Elutia (Nasdaq: ELUT), ein Pionier im Bereich der medikamentenfreisetzenden Biomatrixprodukte, hat seine Teilnahme an der LD Micro Main Event XVII Conference in Los Angeles angekündigt. Dr. Randy Mills, Präsident und CEO, wird am Mittwoch, den 30. Oktober 2024, um 14:00 Uhr PT (17:00 Uhr ET) eine Präsentation halten. Das Management-Team des Unternehmens wird ebenfalls für Einzelgespräche mit institutionellen Investoren zur Verfügung stehen, die Termine über LD Micro-Vertreter oder durch Kontaktaufnahme mit IR@elutia.com vereinbaren können.
- None.
- None.
SILVER SPRING, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XVII Conference in Los Angeles on Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET).
LD Micro Main Event XVII Conference
Presentation Date: Wednesday, October 30, 2024
Presentation Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Click here
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
FAQ
When is Elutia (ELUT) presenting at the LD Micro Main Event XVII Conference?
How can investors schedule 1x1 meetings with Elutia (ELUT) management at the LD Micro conference?
Who will represent Elutia (ELUT) at the LD Micro Main Event XVII Conference?
What is Elutia's (ELUT) main business focus?
